This paper addresses features of UK Patient Information Leaflets (PILs) as originating and shifting from the corresponding Summaries of Product Characteristics (SmPCs). PILs accompany prescription-only and over-the-counter medicines to ensure that all citizens have equal access to reliable and effective quality information. To this purpose, they have been regularly revised by pharmaceutical companies and then validated by the national departments of Health in compliance with national regulations and EU directives and regulations. Alternatively, they are now licensed for use in EU Member States by the European Medicines Agency. The discursive construction of risk (Fage-Butler 2011) and trust generation (Earle 2010) informs patient-centeredness (Balint 1969; Mead, Bower 2000): intralinguistic and intergeneric expert-to-layman translation (Zehtsen 2007) are at work to turn highly specialized Summaries of Product Characteristics (SmPCs) into functionally adequate Patient Information Leaflets (PILs), their closer cognates. These can be seen as seats for Knowledge Dissemination (Calsamiglia, van Dijk 2004), reconceptualization and recontextualization. In his context, it is the purpose of this paper to address questions about the shift from presentation of biomedical research to interactive and patient-friendly communication that pursues engagement with the reader via recourse to general words (as against specialist terms or hypernyms), basic categories (vs. hyponyms) and, importantly, 1st and 2nd person conditionals and 2nd person imperatives and question-answer patterns (as against nominalizations).

On "intralinguistic translation" from summaries of product characteristics to patient information leaflets / Cacchiani, Silvia. - STAMPA. - (2016), pp. 219-251.

On "intralinguistic translation" from summaries of product characteristics to patient information leaflets

CACCHIANI, Silvia
2016

Abstract

This paper addresses features of UK Patient Information Leaflets (PILs) as originating and shifting from the corresponding Summaries of Product Characteristics (SmPCs). PILs accompany prescription-only and over-the-counter medicines to ensure that all citizens have equal access to reliable and effective quality information. To this purpose, they have been regularly revised by pharmaceutical companies and then validated by the national departments of Health in compliance with national regulations and EU directives and regulations. Alternatively, they are now licensed for use in EU Member States by the European Medicines Agency. The discursive construction of risk (Fage-Butler 2011) and trust generation (Earle 2010) informs patient-centeredness (Balint 1969; Mead, Bower 2000): intralinguistic and intergeneric expert-to-layman translation (Zehtsen 2007) are at work to turn highly specialized Summaries of Product Characteristics (SmPCs) into functionally adequate Patient Information Leaflets (PILs), their closer cognates. These can be seen as seats for Knowledge Dissemination (Calsamiglia, van Dijk 2004), reconceptualization and recontextualization. In his context, it is the purpose of this paper to address questions about the shift from presentation of biomedical research to interactive and patient-friendly communication that pursues engagement with the reader via recourse to general words (as against specialist terms or hypernyms), basic categories (vs. hyponyms) and, importantly, 1st and 2nd person conditionals and 2nd person imperatives and question-answer patterns (as against nominalizations).
2016
Language for Special Purposes. Research and Translation across Cultures and Media
Garzone, Giuliana; Heany, Dermot; Riboni, Giorgia
9781443899321
Cambridge Scholars Publishing
REGNO UNITO DI GRAN BRETAGNA
On "intralinguistic translation" from summaries of product characteristics to patient information leaflets / Cacchiani, Silvia. - STAMPA. - (2016), pp. 219-251.
Cacchiani, Silvia
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1119511
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact